Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Shredded cheese sold in dozens of states recalled due to potential for metal fragment contamination - 2‘Integral part of our nation’: Herzog visits Franciscan Sisters in Jerusalem ahead of Christmas
- 3Elite Execution Gaming PCs for Gamers
- 4Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide
- 53 Must-Change Settings for iPhone Clients: Safeguard Yourself !
- Tesla plans to expand production at German car plant
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- Holiday destinations for Creature Sweethearts
- AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- Your big brain makes you human – count your neurons when you count your blessings
- This country music star spent years hiding his sexuality. Coming out — and beating addiction — has made his soul feel '20 pounds lighter.'
- Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
- 'Stranger Things' star debunks claims of 'unseen footage' from Season 5, Volume 2 as backlash intensifies ahead of the series finale
- China and Pakistan issue five-point peace plan for Middle East
